日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Alliance A222001: Oxybutynin Versus Placebo for the Treatment of Hot Flashes in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer

Alliance A222001:奥昔布宁与安慰剂治疗接受雄激素剥夺疗法治疗前列腺癌患者潮热的疗效比较

Stish, Bradley J; Mazza, Gina L; Nauseef, Jones T; Humeniuk, Michael Sandon; Smith, Thomas J; Tofthagen, Cindy; Diaz Pardo, Dayssy Alexandra; Chay, Christopher; Huang, Andrew J; Naha, Kushal; Tagawa, Scott T; Chow, Selina; Ruddy, Kathryn J; Lustberg, Maryam B; Adams-Campbell, Lucile L; Novotny, Paul J; Loprinzi, Charles L

Real-World Outcomes of Elacestrant in ER+, HER2-, ESR1-Mutant Metastatic Breast Cancer

埃拉塞群在ER+、HER2-、ESR1突变型转移性乳腺癌中的真实世界疗效

Rugo, Hope S; Kaklamani, Virginia; McArthur, Heather; Wander, Seth A; Gradishar, William; Mahtani, Reshma; Pegram, Mark; Lustberg, Maryam; Swallow, Elyse; Maitland, Jessica; Kloss, Sebastian; Wasserman, Tomer; Tolaney, Sara M

Machine Learning-Based Prediction of Distant Recurrence Risk and Ribociclib Treatment Effect in HR+/HER2- Early Breast Cancer Using Real-World and NATALEE Data

利用真实世界数据和NATALEE数据,基于机器学习预测HR+/HER2-早期乳腺癌远处复发风险和瑞博西尼治疗效果

Howard, Frederick M; Fasching, Peter A; Santa-Maria, Cesar A; Lim, Elgene; Sparano, Joseph A; Lustberg, Maryam B; Bachelot, Thomas; Blyuss, Oleg; Brezden-Masley, Christine; Park, Yeon Hee; Akdere, Murat; Ye, Fen; Pantoja, Kristyn; Kurz, Christoph; Dominguez Castro, Patricia; Razavi, Pedram

Genomic landscape, immune microenvironment and survival in male versus female breast cancer

基因组图谱、免疫微环境与男性和女性乳腺癌患者的生存率

Trapani, D; Deshmukh, S K; Samec, T; Wu, S; Xiu, J; Walker, P; Abravanel, D L; Advani, P; Spanheimer, P M; Lin, N U; Curigliano, G; Graff, S L; Lustberg, M; Sledge, G W; Tolaney, S M; Leone, J P

Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer.

定量 HER2 组织和血浆分析可预测曲妥珠单抗 deruxtecan 对乳腺癌的活性。

Tarantino Paolo, Kim Se-Eun, Hughes Melissa E, Kusmick Ross J, Smith Kalie, Brasó-Maristany Fara, Nyein Chan Nay Nwe, Paré Brunet Laia, Alder Laura, Garcia-Cortes Diana, Gomez Tejeda Zanudo Jorge, Pereslete Alyssa M, Noteware Laura, Moore Heather, Van Swearingen Amanda E D, Li Tianyu, Gupta Hersh, D'Amico Olivia, Martini Alba, Morganti Stefania, Spindel Jennifer, Cook Charmaine, McLaughlin Christine, Dvir Kathrin, Garrido-Castro Ana C, Sammons Sarah, Files Janet, Sendrick Kerry, Buck Simone, Dillon Deborah, Jeselsohn Rinath, Li Yvonne Y, Cherniack Andrew D, LoRusso Patricia, Lustberg Maryam, Vega-León Rosario, Pardo Francisco, Davis Justin, Mueller Claudius, Corgiat Brian, Curigliano Giuseppe, Anders Carey K, Petricoin Emanuel F, Rimm David L, Prat Aleix, Tayob Nabihah, Lin Nancy U, Tolaney Sara M

EGFR amplification and PI3K pathway mutations identify a subset of breast cancers that synergistically respond to EGFR and PI3K inhibition

EGFR扩增和PI3K通路突变可识别出一部分对EGFR和PI3K抑制剂具有协同反应的乳腺癌亚群。

David J Wisniewski,Donna Voeller,Yonit A Addissie,Sachin Kumar Deshmukh,Sharon Wu,Maryam B Lustberg,Darawalee Wangsa,Danny Wangsa,Kerstin Heselmeyer-Haddad,Yoshimi Endo Greer,George W Sledge,Stanley Lipkowitz

Dance-based avenues to advance nonpharmacologic treatment of chemotherapy effects (DAANCE): study protocol for a multi-center, randomized controlled trial

利用舞蹈疗法促进化疗副作用的非药物治疗(DAANCE):一项多中心随机对照试验的研究方案

Luciani, Bhillie D; Alwan, Aya; Carlson, Martha; McNally, Gretchen; Hackney, Madeleine E; Crasta, Jewel E; Schnell, Patrick; Lustberg, Maryam B; Worthen-Chaudhari, Lise

Epigenetic activation of EBV BGLF4 determines antiviral-based regimen response in EBV+CNS lymphoproliferative disease

EBV BGLF4 的表观遗传激活决定 EBV 阳性中枢神经系统淋巴增生性疾病的抗病毒治疗方案反应。

Weigel, Christoph; Klimaszewski, Haley L; Tounkara, Fode; Addissie, Selamawit; Schlotter, Sarah; Pray, Betsy; Dugan, James P; Haverkos, Bradley M; Villagomez, Lynda; Lustberg, Mark; Porcu, Pierluigi; Voorhees, Timothy; Ambinder, Richard F; Kenney, Shannon C; Fingeroth, Joyce; Delecluse, Henri-Jacques; Caligiuri, Michael A; Alinari, Lapo; Bumgardner, Ginny; Oakes, Christopher C; Baiocchi, Robert A

Screening History, Stage at Diagnosis, and Mortality in Screen-Detected Breast Cancer

筛查史、诊断分期和筛查发现的乳腺癌死亡率

Huang, Sida; Westvold, Sarah J; Soulos, Pamela R; Fan, Jane; Winer, Eric P; Zhan, Haiying; Lustberg, Maryam B; Lewin, John; Robinson, Timothy J; Dinan, Michaela A

Outcomes with trastuzumab deruxtecan by biomarker status, line of treatment and prior receipt of sacituzumab govitecan in a large real-world database of patients with metastatic breast cancer

在大型真实世界数据库中,根据生物标志物状态、治疗线数和既往是否接受过沙妥珠单抗戈维替康治疗,分析了曲妥珠单抗德鲁西替康治疗转移性乳腺癌患者的疗效

Tarantino, P; Lee, D; Foldi, J; Soulos, P R; Gross, C P; Grinda, T; Winer, E P; Lin, N U; Krop, I E; Tolaney, S M; Lustberg, M; Sammons, S